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Abstract
Living organisms are continuously exposed to a myriad of DNA damaging agents that can impact 
health and modulate disease-states. However, robust DNA repair and damage-bypass mechanisms 
faithfully protect the DNA by either removing or tolerating the damage to ensure an overall 
survival. Deviations in this fine-tuning are known to destabilize cellular metabolic homeostasis, as 
exemplified in diverse cancers where disruption or deregulation of DNA repair pathways results in 
genome instability. Because routinely used biological, physical and chemical agents impact human 
health, testing their genotoxicity and regulating their use have become important. In this 
introductory review, we will delineate mechanisms of DNA damage and the counteracting repair/
tolerance pathways to provide insights into the molecular basis of genotoxicity in cells that lays 
the foundation for subsequent articles in this issue.
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Introduction
Preserving genomic sequence information in living organisms is important for the 
perpetuation of life. At the same time, mutagenesis plays an indispensible part in its 
maintenance and evolution, while also contributing to cancer, certain human diseases and 
aging. It is known that DNA, the basic unit of inheritance, is an intrinsically reactive 
molecule and is highly susceptible to chemical modifications by endogenous and exogenous 
agents. Furthermore, the DNA polymerases engaged in DNA replication and repair make 
mistakes, thereby burdening cells with potentially disadvantageous mutations. However, 
cells are equipped with intricate and sophisticated systems—DNA repair, damage tolerance, 
cell cycle checkpoints and cell death pathways—that collectively function to reduce the 
deleterious consequences of DNA damage.
Cells respond to DNA damage by instigating robust DNA damage response (DDR) 
pathways, which allow sufficient time for specified DNA repair pathways to physically 
remove the damage in a substrate-dependent manner. At least five major DNA repair 
pathways—base excision repair (BER), nucleotide excision repair (NER), mismatch repair 
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(MMR), homologous recombination (HR) and non-homologous end joining (NHEJ)—are 
active throughout different stages of the cell cycle, allowing the cells to repair the DNA 
damage. A few specific lesions can also be removed by direct chemical reversal and 
interstrand crosslink (ICL) repair. These repair processes are key to maintaining genetic 
stability in cells. In addition, certain types of DNA damage are substrates for the DNA 
damage tolerance pathways. In higher eukaryotes, for example, a well-orchestrated group of 
five main translesion synthesis (TLS) polymerases—REV1, POL ζ, POL η, POL κ and POL 
ι—bypass the damage to enable the continuation of replication, but with the possibility of a 
concurrent introduction of an incorrect base that can be fixed into a mutation in the 
subsequent round of replication. Under the circumstances, when the damaged DNA persists, 
programmed cell death or apoptosis, a regulatory response to DNA damage, is activated to 
get rid of cells with extensive genome instability.
Not surprisingly, in many cancers, DNA repair, DNA damage tolerance and DDR pathways 
are disrupted or deregulated, which increases mutagenesis and genomic instability, thereby 
promoting cancer progression [Bouwman and Jonkers, 2012; Ghosal and Chen, 2013; 
Wolters and Schumacher, 2013]. Likewise, aging is attributed to attrition of chromosomal 
ends and failing capacities of a combination of these pathways. Other diseases, such as 
neurodegenerative disorders, result from a combinatorial failure of more than one of these 
processes. The 2015 Nobel Prize in Chemistry to Drs. Lindahl, Modrich and Sancar 
highlights the importance of mechanisms of DNA damage and repair and their implications 
for human health. In this review we will discuss the details of various types and mechanisms 
of DNA damage and the compensatory repair and tolerance pathways.
Types of DNA damage
DNA damage can be categorized into two main classes based on its origin: endogenous and 
exogenous. The majority of the endogenous DNA damage arises from the chemically active 
DNA engaging in hydrolytic and oxidative reactions with water and reactive oxygen species 
(ROS), respectively, that are naturally present within cells. Such inherently predisposed 
reactions of DNA with molecules from its immediate surroundings fuel the development of 
hereditary diseases and sporadic cancers [Visconti and Grieco, 2009; Reuter et al., 2010; 
Perrone et al., 2016]. Exogenous DNA damage, on the other hand, occurs when 
environmental, physical and chemical agents damage the DNA. Examples include UV and 
ionizing radiation, alkylating agents, and crosslinking agents. We offer here a brief summary 
of the main endogenous and environmental agents that produce the different classes of DNA 
damage that then become substrates for the specific DNA repair pathways discussed in the 
subsequent section.
Endogenous DNA damage
Replication errors, DNA base mismatches and topoisomerase-DNA complexes
Every time a human cell replicates, approximately 3 X 109 bases are copied over by high 
fidelity replicative polymerases (δ and ε). However, a battery of other DNA polymerases (α, 
β, σ, γ, λ, REV1, ζ, η, ι, κ, θ, ν, μ, Tdt and PrimPol) can carry out lower fidelity DNA 
synthesis during DNA replication or repair (Table 1) [Loeb and Monnat (2008)]. High 
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fidelity DNA synthesis is a consequence of structural and biochemical attributes of 
replicative DNA polymerases, which ensure the insertion of a correct complementary 
deoxynucleotide opposite the template base. This is accomplished, for instance, by: 1) the 
thermodynamic stability and base-pair energetics of the incoming dNTP and template base, 
2) the geometric selection of a correctly shaped and sized dNTP in the polymerase’s active 
site, and 3) removing an incorrectly inserted deoxynucleotide by a 3′-5′ deoxynucleotide 
exonuclease. In addition, the mismatch repair (MMR) pathway contributes to replication 
fidelity by more than 100-fold by correcting the rare errors that have escaped proofreading 
by replicative polymerases [Kunkel, 2004; Kunkel, 2009; Kunkel, 2011].
Nevertheless, base substitutions and single base insertion and deletion errors still accumulate 
at a frequency of 10−6 to 10−8 per cell per generation [Kunkel, 2004; Kunkel, 2009]. 
Additional replication errors accumulate from strand slippage events at repetitive sequences 
causing insertions and deletions of nucleotides that can potentially change the reading frame 
[Viguera et al., 2001; Chatterjee N., 2013]. Other times, the replicative polymerases 
incorrectly incorporate uracil in the DNA or end up with a compromised fidelity because of 
the alterations of the relative and absolute concentrations of dNTPs and rNTPs within the 
cell’s environment [Andersen et al., 2005; Vertessy and Toth, 2009; Kumar et al., 2011; 
Clausen et al., 2013; Buckland et al., 2014; Potenski and Klein, 2014]. These incorrectly 
paired/incorporated nucleotides that escape proofreading and MMR become mutations in the 
next round of replication and are a major source of spontaneous mutagenesis.
Another source of endogenous DNA damage results from the action of topoisomerase 
enzymes (for example: TOP I, TOP II, TOP III; 7 TOP genes are found in the human 
genome), which primarily remove superhelical tension on DNA during replication and 
transcription [Wang, 2002; Pommier et al., 2006]. TOP1, for example, transiently nicks the 
supercoiled DNA and facilitates rotation of the broken strand around the TOP1-bound DNA 
strand to relax the DNA. Thereafter, TOP1 religates the breaks by aligning the 5′-OH group 
of the DNA with the tyrosine-DNA phosphodiester bond to resolve the complex [Stewart et 
al., 1998; Carey et al., 2003]. Misalignment of the 5′-OH DNA end stabilizes the cleavage 
complex to form a DNA lesion [Pommier and Cherfils, 2005; Pommier and Marchand, 
2005]. Interestingly, anticancer drugs such as camptothecin and many naturopathic 
compounds are known to stabilize the TOP1-DNA cleavage complexes [Staker et al., 2002; 
Han et al., 2008]. Additionally, DNA adducts (from UV and benzene derivatives) and 
aberrant DNA structures (nicks, mismatches, abasic sites) can also irreversibly trap the 
TOP1-DNA cleavage complex into DNA lesions called suicidal complexes [Burgin et al., 
1995; Pourquier and Pommier, 2001; Meng et al., 2003]. TOP1-associated DNA damage is 
usually repaired by reversal of these complexes or is excised by TDP1 (tyrosyl DNA 
phosphodiesterase) and endonucleases [Pommier et al., 2006].
Spontaneous base deamination
Base deamination is a major source of spontaneous mutagenesis in human cells, where 
cytosine (C), adenine (A), guanine (G), and 5-methyl cytosine (5mC) in DNA lose their 
exocyclic amine to become uracil (U), hypoxanthine, xanthine and thymine (T), respectively 
(Figure 1B). Interestingly, these base deamination events occur at a much higher frequency 
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in single-stranded versus double-stranded DNA and are often exacerbated by transient single 
strandedness during active replication, transcription and recombination [Lindahl, 1993; 
Yonekura et al., 2009]. In the case of deamination of cytosine, for instance, the native C:G 
base pairing alters to a U:A base pair in the first round of replication, which in the next 
round of replication results in a CG→TA mutation. Cytosine and 5-methyl cytosine are the 
most frequently deaminated, but 5-methyl cytosine is deaminated three to four times more 
frequently than cytosine [Lindahl, 1979]. While deaminated cytosine is rapidly removed 
from DNA by uracil-DNA glycosylase, the G:T base pair resulting from deamination of 5-
methylcytosine is instead a substrate for the thymine DNA glycosylase (TDG) and the 
relatively slow MMR process [Lindahl, 1979; Wiebauer and Jiricny, 1990; Waters and 
Swann, 1998]. Consequently, the GC→AT transition at the CpG sequences accounts for 
one-third of the single site mutations responsible for hereditary diseases in humans [Cooper 
and Youssoufian, 1988; De Bont and van Larebeke, 2004].
Paradoxically, cytosine deamination is also a normal route for somatic hypermutagenesis 
during antibody development due to the action of the deaminase enzymes AID (activation-
induced deaminase) and APOBEC1 (Apolipoprotein B mRNA editing enzyme catalytic 
polypeptide 1), which mediate host defense against reteroviruses [Goff, 2003; Blanc and 
Davidson, 2010; Chandra et al., 2015]. In addition to the endogenous deamination sources, 
environmental exposure to UV radiation, intercalating agents, nitrous acid and sodium 
bisulfite can in general enhance base deamination rates in the DNA [Chen and Shaw, 1993; 
Moyer et al., 1993; Pfeifer et al., 2005; d’Ischia et al., 2011]. From an evolutionary 
standpoint, cytosine deamination from endogenous and exogenous sources may serves as a 
source for genetic diversity [Fryxell and Zuckerkandl, 2000; Nabel et al., 2012].
Abasic sites
Abasic or AP (apurinic/apyrimidic) sites are continuously created in the DNA when the N-
glycosyl bond, which links the nitrogenous base and the sugar phosphate backbone, either 
hydrolyzes spontaneously or gets cleaved by a DNA glycosylase to generate an intermediate 
in the BER pathway. For example, AP sites are formed when uracil is removed from the 
DNA by uracil-DNA glycosylase [Lindahl and Barnes, 2000]. In a human cell, about 10,000 
abasic sites are created per day; both extreme pH conditions and high temperatures 
positively impact their generation [Lindahl, 1993; Tropp, 2011]. Abasic sites are inherently 
unstable and readily convert into single strand breaks (SSBs) from a β-elimination reaction 
that targets the 3′ phosphodiester bond of the leftover deoxyribose [Bailly and Verly, 1988; 
Waters and Walker, 2006; Tropp, 2011; Chan et al., 2013]. Most AP sites are effectively 
removed by AP endonucleases that cleave at their 5′ end and allow the BER pathway to 
repair them. Alternatively, AP sites can be bypassed by TLS polymerases [Chan et al., 
2013]. It is not known whether other exogenous stresses could also directly propel the 
formation of AP sites in the genome.
Oxidative DNA damage
Reactive oxygen species (ROS) are the typical byproducts of the electron transport chain 
(ETC) during cellular respiration in aerobic organisms, and are additionally derived from 
catabolic oxidases, anabolic processes and peroxisomal metabolism [Henle and Linn, 1997]. 
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At low levels, ROS species perform important cellular functions such as serving as cellular 
messengers in redox signaling reactions and effecting important defense responses to 
invading pathogens by the immune system [Errol C. Friedberg, 2005; Segal, 2005; Malle et 
al., 2007]. However, in excess, ROS species can cause a total of approximately 100 different 
oxidative base lesions and 2-deoxyribose modifications [Bjelland and Seeberg, 2003; Cadet 
et al., 2010; Cadet et al., 2011; Cadet et al., 2012; Ravanat et al., 2012; Cadet and Wagner, 
2014]. Ordinarily, the deleterious consequences of ROS are regulated in cells by 1) 
restricting respiration in the mitochondrial compartment, thereby protecting other cellular 
components, 2) protecting DNA by complexing it with histones, and 3) quenching of surplus 
ROS species by the anti-oxidant enzymes superoxide dismutase, catalase, and peroxiredoxin 
[Riley, 1994; Mates et al., 1999; Mates and Sanchez-Jimenez, 1999]. Despite this, an 
overabundance of ROS species is notably associated with the development of human 
diseases, such as cancer, Alzheimer’s disease, Parkinson’s disease, diabetes, and heart 
failure [Giacco and Brownlee, 2010; Liou and Storz, 2010; Mohsenzadegan and Mirshafiey, 
2012; Dias et al., 2013; Hafstad et al., 2013].
The most conspicuous of the ROS species are the superoxide radicals (•O2−), hydrogen 
peroxide (H2O2), and the hydroxyl radical (•OH) [Tropp, 2011]. Amongst these ROS 
species, the •OH radical, produced as a byproduct of a Fenton’s reaction of H2O2 with Fe2+, 
is by far the most reactive, and is capable of damaging DNA, proteins and lipids [Imlay et 
al., 1988; Dizdaroglu et al., 1991]. These electrophilic •OH radicals react with DNA bases 
by 1) adding to their double bonds, 2) abstracting hydrogen atoms from their methyl groups, 
and 3) attacking the sugar residue in their immediate vicinity [Breen and Murphy, 1995; 
Winterbourn, 2008]. For example, thymine glycol residues are generated from a •OH attack 
on the C5/C6 double bonds of thymine (Figure 1C). Similarly, the •OH radical produced as a 
byproduct of the Fenton reaction of H2O2 and Fe2+ induces an imidazole ring opening in 
guanine and adenine to form the fragmented purine structure formamidopyrimidine (Figure 
1C) [Chetsanga et al., 1981; Errol C. Friedberg, 2005; C., 2006]. Another biologically 
significant and major oxidative base lesion formed from hydroxylation of the C-8 residue of 
guanine is the saturated imidazole ring 7,8 dihydro-8-oxoguanine (8-oxo-G) (Figure 1C). 8-
oxo-guanine pairs incorrectly with adenine instead of cytosine, thereby adding to the overall 
mutational load, and is further oxidized to other deleterious secondary DNA lesions because 
of its low oxidation potential [Kasai and Nishimura, 1984; Cheng et al., 1992; Cadet et al., 
1999; Cadet et al., 2010].
Other than attacking DNA bases, ROS radicals can also compromise the DNA backbone 
causing an estimated 2300 single strand breaks per cell per hour in mammalian cells [Giloni 
et al., 1981; R, 1981; Henner et al., 1983a; Henner et al., 1983b]. While the BER pathway 
repairs the oxidized bases, the breaks in the DNA backbone are repaired by the single strand 
break repair (SSBR) pathways or the double strand break repair (DSBR) pathways [Henner 
et al., 1983a; Demple and Harrison, 1994]. Finally, lipid peroxidation, the oxidation of lipid 
molecules by hydroxyl radicals, generates aldehyde products such as malondialdehyde and 
4-hydroxynonenal, which can react with adenine, guanine and cytosine to form mutagenic 
adducts [Marnett, 2000; Plastaras et al., 2000; VanderVeen et al., 2001]. About 1 adduct per 
106 – 107 parent DNA bases results from lipid peroxidation events and the number of 
mutagenic adducts are expected to be even higher for metal storage diseases such as 
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Wilson’s disease and hemochromatosis [Carmichael et al., 1995; Luczaj and Skrzydlewska, 
2003; Broedbaek et al., 2009].
DNA methylation
S-adenosylmethionine (SAM), which is used as a methyl donor by methyl transferases 
during normal methylation reactions, can also spontaneously generate up to 4000 N7-
methylguanine, 600 N3-methyladenine and 10–30 O6-methylguanine residues per cell per 
day in mammals (Figure 1d) [Rydberg and Lindahl, 1982; Holliday and Ho, 1998; De Bont 
and van Larebeke, 2004]. Other methylating agents include endogenous nitrosated bile salts, 
betaine, choline, and environmental agents such as tobacco smoke, diet, pollution or 
derivatives of N-nitroso compounds [O’Driscoll et al., 1999; Zhao et al., 1999]. O6-
methylguanine and the related residues O4-methylthymine and O4-ethylthymine are highly 
mutagenic, producing G:C→A:T and T:A→C:G transition mutations, respectively. In 
contrast, N3-methyladenine is only partly cytotoxic due to inhibition of DNA synthesis, 
while the N7-methylguanine residue is essentially harmless unless it undergoes a 
spontaneous cleavage to generate an AP site or opens the imidazole ring to form 
formamidopyrimidine [Loveless, 1969; Loechler et al., 1984; Larson et al., 1985; Preston et 
al., 1986; Preston et al., 1987; O’Connor et al., 1988; Singer et al., 1989; Tudek et al., 1992]. 
Other minor methyl lesions produced by SAM are the mutagenic N3-methylthymine and 
N3-methylcytosine (Figure 1D) [Boiteux and Laval, 1982; Saffhill, 1985; Huff and Topal, 
1987].
Methylated bases are removed from DNA by two main pathways: 1) direct reversal of the 
DNA damage by O6-methylguanine DNA methyltransferase or by oxidation by an α-
ketoglutarate-dependent dioxygenase AlkB homolog, and 2) BER, which is initiated by 
DNA glycosylases to remove the methylated bases by catalyzing the cleavage of their 
glycosidic bonds [Sakumi and Sekiguchi, 1990; Tudek et al., 1992; Huang et al., 1994; Zak 
et al., 1994; Ye et al., 1998]. In addition, the O6-methylguanine DNA lesion interestingly 
triggers a cytotoxic and futile cycle of MMR, by means of its abnormal base pairing with 
other residues [Branch et al., 1993; Kat et al., 1993]. If left unrepaired, methylated DNA 
bases are a major source of spontaneous DNA damage. Alkylated DNA damage from 
exogenous compounds will be discussed later in the article.
Exogenous DNA damage
Ionizing Radiation (IR)
Ionizing radiation, composed of alpha, beta, gamma, neutrons and X-rays, is abundant in our 
environment, being produced from diverse sources ranging from rocks, soil, and radon, to 
cosmic radiation and medical devices. Each type of radiation can be classified to describe its 
effect (direct or indirect) and ionization density (linear energy transfer (LET)). Depending 
on the amount of energy transferred to matter, radiations are classified as either high LET 
(alpha rays) or low LET (beta and gamma). Cumulatively, IR can damage the DNA either 
directly, or by indirect means, such as by radiolysis of the surrounding water to generate a 
cluster of highly reactive hydroxyl radicals (•OH) [Errol C. Friedberg, 2005; Omar 
Desoukya, 2015]. The presence of oxygen and other reactive species in the surrounding also 
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potentiates the formation of other DNA-reactive free radicals by IR [Wardman, 2009]. In 
fact, indirect DNA damage from (•OH) radicals accounts to about 65% of the radiation-
induced DNA damage [Vignard et al., 2013]. Because of this, IR produces a spectrum of 
base lesions that is similar to that generated by ROS species (see previous section). Major 
lesions include 8-oxo-guanaine, thymine glycol and formamidopyrimidines (Figure 1C).
Apart from causing base lesions, ionizing radiation also causes single strand breaks with a 
unique signature, where the DNA breaks have 3′ phosphate or 3′-phosphoglycolate ends 
rather than 3′-OH ends. In addition, fragmented sugar derivatives and loss of terminal base 
residues culminate into clustered damage or single stranded gaps [Henner et al., 1982; 
Henner et al., 1983b; Obe et al., 1992]. AP endonucleases, polynucleotide kinase/
phosphatase (PNKP) and tyrosyl DNA phosphodiesterase 1 (TDP1) can efficiently process 
the modified ends and enable repair of the IR-induced single strand beaks [Price, 1993; 
Jilani et al., 1999; Zhou et al., 2005; El-Khamisy et al., 2007]. A particularly important 
radiation-induced lesion is the double strand break, formed from multiple damaged sites 
closely positioned on both DNA strands [Hutchinson, 1985; Iliakis, 1991]. Although toxic, 
IR-induced double strand breaks can be repaired by the HR pathway [Lomax et al., 2013].
Ultraviolet (UV) radiation
UV radiation emanating from the sun is the leading cause of skin cancers in humans 
[Davies, 1995; KIEFER, 2007]. Typically, UV radiation is categorized into three classes 
based on the range of wavelength: UV-C (190–290 nm), UV-B (290–320 nm) and UV-A 
(320–400nm). DNA absorbs maximal UV radiation at 260 nm, beyond which the photo-
absorption drops dramatically. Sunlight is composed of 5.1% UV-A, 0.3% UV-B, 62.7% 
visible light and 31.9% infrared, as the hazardous UV-C is mostly filtered out by the ozone 
layer [Davies, 1995]. The effects of UV on matter are disseminated in two ways. First, if the 
UV is absorbable, molecules in matter are excited leading to their photochemical alteration. 
Second, if UV cannot be directly absorbed, energy transfer from nearby molecules called 
photosensitizers indirectly affects matter. UV damage DNA by both pathways.
Laboratory studies have shown that UV-C damages DNA primarily by causing covalent 
linkages between two adjacent pyrimidines. Here the two major photoproducts are the 
cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6 – 4) pyrimidone photoproducts ((6 
– 4) PPs) (Figure 2). Their relative formation frequency depends on wavelength and dose of 
light [Varghese, 1972; Mitchell and Nairn, 1989; Davies, 1995], although, the yield of (6 – 
4) PP is slightly less than CPDs [Mitchell and Nairn, 1989]. Other minor photoproducts are 
also generated, such as pyrimidine hydrate, thymine glycols, and dipurine adducts [Demple 
and Linn, 1982; Bose et al., 1983; Kumar et al., 1991; Mitchell et al., 1991]. In CPDs, a 
cyclobutane ring covalently links the two adjacent pyrimidines, whereas in (6 – 4) PP, the C6 
position of one pyrimidine is covalently linked to C4 position of the adjacent pyrimidine. 
These bulky dimers distort the helix, requiring TLS polymerases for replication past them, 
thereby contributing to mutagenicity. For example, C:G→T:A, T:A→C:G and characteristic 
tandem CC→TT transition mutations result from pyrimidine dimers [Chan et al., 1985; 
Dumaz et al., 1993; Gentil et al., 1996; Naegeli, 1997]. An interesting attribute of the (6 – 4) 
PP is that it undergoes photoisomerization to a Dewar valence isomer in the presence of UV-
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B, while reverting to the conventional (6 – 4) PP structure when exposed to UV-C light 
[Mitchell and Nairn, 1989; Davies, 1995]. If these lesions are left unrepaired or are not 
bypassed, they result in cytotoxicity.
UV-C is widely used in laboratory investigations because of its maximal absorption by 
DNA, producing more photoproducts than the UV-A and UV-B radiations, which are also 
physiologically relevant UV wavelengths that also cause DNA damage [KIEFER, 2007]. 
UV-B for instance causes the formation of pyrimidine dimers, but does so less efficiently 
than UV-C [You et al., 2000; Errol C. Friedberg, 2005; Rastogi et al., 2010]. UV-A damages 
DNA by inducing DNA adduct formation by photooxidation reactions and by the excitation 
of endogenous (porphyrins and flavins) and exogenous (psoralens, tetracycline, promazine 
and methylene blue) photosensitizers [Epe, 1991; Kvam and Tyrrell, 1997; Douki et al., 
1999]. In addition, UV-A-mediated photosensitization can induce 8-oxoG formation or an 
excess accumulation of cyclobutane dimers [Epe, 1991; Rochette et al., 2003]. In 
mammalian cells, near and far UV radiations are known to cause DNA protein crosslinks, 
while UV-A radiation results in DNA strand breakages [Peak and Peak, 1986; Errol C. 
Friedberg, 2005]. UV lesions are repaired by direct reversal of UV-damaged bases, NER, 
interstrand crosslink (ICL) repair, translesion synthesis, or homologous recombinations 
(HR), all of which either repair the lesions or enable cells to tolerate their presence [Sancar, 
1996; Errol C. Friedberg, 2005; Waters and Walker, 2006; Eppink et al., 2011].
Exogenous chemical agents
Alkylating agents
Exogenous alkylating agents are primarily produced from dietary components, tobacco 
smoke, biomass burning, industrial processing and chemotherapeutic agents [Lawley, 1966; 
AE, 1990; Crutzen and Andreae, 1990]. The electrophilic alkylating agents react with 
increased affinity to the highly nucleophilic base ring nitrogens, especially the N7 of 
guanine and N3 of adenine, and slightly less so with the oxygens. Examples of adducted 
DNA bases include modified adenine (at N1, N3, N6 and N7), guanine (N1, N2, N3, N7 and 
O6), cytosine (N3, N4 and O2), thymine (N3, O2 and O4), and alkyl phosphates in the DNA 
backbone (exocyclic positions on DNA bases are in italicized superscripts) [Singer and 
Kusmierek, 1982; Singer, 1986; Errol C. Friedberg, 2005]. Mechanistically, alkylating 
agents add the alkyl group by either 1) an SN1 substitution reaction that progresses via the 
first order kinetics and involves a carbonium ion intermediate, or, 2) an SN2 substitution 
reaction that follows the second order kinetics, and in general produces adducts that are less 
mutagenic and carcinogenic than those of the SN1 pathway [Naegeli, 1997], although 
evidence has been presented that some SN1 alkylating agents may not proceed via the 
carbonium ion intermediate [Loechler, 1994].
Most common alkylating agents that are regularly used in labs, including methyl 
methanesulfonate (MMS), ethyl methanesulfonate (EMS), N-methyl -N′ –nitro-N-
nitrosoguanidine (MNNG) and methylnitrosourea (MNU) (Figure 3A), react with DNA to 
generate mutagenic and carcinogenic lesions. For example, MMS produces the mutagenic 
N7-methylguanine and N3-methyladenine, both of which are susceptible to cleavage of the 
N-glycosidic bond, thereby generating AP sites, while MNNG and MNU produce O6-
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methylguanine, which mispairs with T and induces G:C→A:T mutations [Loechler et al., 
1984; Beranek, 1990; Wyatt and Pittman, 2006].
Other classical examples of alkylating agents are sulfur and the nitrogen mustards, first used 
in World War I, and in many other conflicts since including the present day Syria. The 
mustards drive SN1 reactions, and are bifunctional in that they carry two reactive groups, 
instead of one as in monofunctional alkylating agents, and thus have the potential to react 
with two different sites on the DNA. Such bifunctional reactions result in intra- and 
interstrand crosslinks, along with the DNA-protein crosslinks, which block DNA metabolic 
activity [Lawley, 1966; AE, 1990]. These properties of the mustards have been exploited in 
their use as chemotherapeutic alkylating agents [DeVita and Chu, 2008]. One clinically 
relevant alkylating agent for chemotherapy is cyclophosphamide (Figure 3B) used in the 
treatment of lymphomas, leukemias and solid tumors [Emadi et al., 2009]. Another class of 
crosslinking agents that are used in chemotherapy includes cisplatin (Figure 3B), the first 
FDA approved platinum compound that is used to treat a wide variety of cancers [Kelland, 
2007; Dasari and Tchounwou, 2014]. A crosslinking agent that is not an alkylating agent, 
psoralen (a furocoumarin) (Figure 3B), intercalates into DNA and cause both interstrand 
crosslinks and pyrimidine adducts upon photoactivation by UV-A [Yurkow and Laskin, 
1991]. The combined psoralen+UV-A or PUVA has been effectively used for treating skin 
conditions such as psoriasis, eczema and cutaneous T-cell lymphomas. Direct damage 
reversal, BER and ICL repair are the putative repair pathways that respond to alkylated base 
damage [Wyatt and Pittman, 2006].
Aromatic amines
Aromatic amines are principally produced from cigarette smoke, fuel, coal, industrial dyes, 
pesticides and everyday high temperature cooking [Sugimura, 1986; Skipper et al., 2010]. 
Upon activation by the P450 monooxygenase system, aromatic amines are converted into the 
carcinogenic (ester and sulfate) alkylating agents that attack the C8 position of guanine 
[Hammons et al., 1997; Naegeli, 1997]. The most intensively studied examples of aromatic 
amines are 2-aminofluorene (AF) and its acetylated derivative N-acetyl-2-aminofluorene 
(AAF) (Figure 3C), which were originally used as insecticides until they were recalled due 
to their carcinogenic properties [Kriek, 1992]. C8-guanine lesions formed from 
aminofluorenes are known to form persistent lesions that ultimately give rise to base 
substitutions and frameshift mutations [Mah et al., 1989; Heflich and Neft, 1994; Shibutani 
et al., 2001]. The mutagenic properties of the C8-guanine lesion come from its characteristic 
ability to adopt two conformations while on the DNA [Eckel and Krugh, 1994a]. In the 
external conformation where the fluorene moiety protrudes out, there is minimal disturbance 
to Watson-Crick base pairing, which allows these isomers to be effectively bypassed by TLS 
polymerases [Vooradi and Romano, 2009]. While in internal conformation, the C8-guanine 
lesion and its partner cytosine are displaced into the minor groove, completely altering the 
geometry and acting as a very mutagenic substrate on the DNA [Kriek, 1992; Eckel and 
Krugh, 1994a; Eckel and Krugh, 1994b]. The NER pathway is known to repair C8-guanine 
adducts in human cells [Mu et al., 2012]
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Polycyclic aromatic hydrocarbon (PAH)
Polycyclic aromatic hydrocarbons are carbon compounds with two or more aromatic rings 
and are generally known to be inert, nonpolar and widely distributed carcinogens in the 
environment [Harvey, 1991]. Common sources include tobacco smoke, automobile exhaust, 
charred food and incomplete combustion of organic matter and fossil fuels [Schoket, 1999; 
Yu, 2002]. The carcinogenicity of these compounds was first documented in 1775, followed 
by their isolation from coal tar and the later elucidation of their mechanism of action [Butlin, 
1892; Phillips, 1983; Fujiki, 2014]. PAHs depend on the P-450 system of the liver to 
generate reactive intermediates that react with DNA [Phillips, 1983]. Photo-oxidation, one 
electron oxidation, multiple ring-oxidation and nitrogen-reduction pathways are also known 
to activate the PAHs [Strniste et al., 1980; Fu, 1990; RamaKrishna et al., 1992; Rogan et al., 
1993; Flowers et al., 1997; Penning et al., 1999; Yu, 2002].
Prominent examples of PAHs are naphthalene, anthracene, pyrene, 1-hydroxypyrene, 1-
nitropyrene, benzo(a)pyrene and dibenzo[a,l]pyrene. Of these, the most well studied is 
benzo(a)pyrene (Figure 3D). Upon P-450 activation, benzo(a)pyrene generates the ultimate 
carcinogen (+)-anti-BPDE [(+)- 7,8-hydroxy-9α, 10α-epoxy-7,8,9,10-
tetrahydrobenzo(α)pyrene], along with the (+)-anti-BPDE and the (−)-anti-BPDE 
intermediates. These intermediates first intercalate into DNA, then the C10 position of the 
BPDE binds to the N2 exocyclic position of guanine to form DNA adducts [Geacintov, 1986; 
Graslund and Jernstrom, 1989; Cosman et al., 1992]. In terms of carcinogenicity, 
dibenzo[a,l]pyrene (Figure 3D) is the most potent PAH and poses a major cancer risk to 
humans [Luch, 2009]. Normally, the excision repair pathways such as NER and BER repair 
the PAH DNA lesions if they are not bypassed by TLS polymerases [Braithwaite et al., 
1998; Jha et al., 2016].
Other reactive electrophiles
Given the space constraint and scope of this manuscript, we will only briefly touch upon a 
few other relevant reactive electrophiles that damage the DNA. N-nitrosamines, which are 
potent carcinogens, are byproducts of tobacco smoke and are also encountered by humans in 
preserved meats. N-nitrosamines have been implicated in the development of esophagus, 
stomach and nasopharynx cancers [Bartsch and Montesano, 1984; Tricker and Preussmann, 
1991; Hecht, 1999; Herrmann et al., 2015]. Another reactive electrophile, 4-nitroquinoline 
1-oxide, has both carcinogenic and mutagenic properties (Figure 3E). Upon its metabolic 
activation to 4-acetoxyaminoquinoline 1-oxide (Ac-4HAQO), 4NQO1 forms covalent 
adducts with C8 or N2 of guanine and N6 of adenine, as well as causing oxidative stress that 
results in 8-hydroxyguanine lesion, all of which significantly adds to the strand breakage 
events and oral carcinogenesis [Galiegue-Zouitina et al., 1985; Galiegue-Zouitina et al., 
1986; Kohda et al., 1986; Hawkins et al., 1994; Kanojia and Vaidya, 2006].
Our final notable compound is the hormone estrogen, frequently used in hormonal 
replacement therapy, which poses a cumulative increased cancer risk after its prolonged use 
[Cavalieri et al., 2000; Yager and Davidson, 2006]. Epidemiological and clinical trial studies 
indicate an increased breast cancer risk and other health issues from a combinatorial use of 
estrogen and progesterone compared to estrogen alone [Yager and Davidson, 2006]. The 
Chatterjee and Walker Page 10
Environ Mol Mutagen. Author manuscript; available in PMC 2018 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
P-450 1BI enzyme complex, constitutively expressed in breast and other tissues, 
hydroxylates estrogen at position 4 to produce reactive catechol estrogens, which are either 
oxidized to semiquinones and quinones that react with N3 and N7 position of purines, or 
generate ROS species [Nutter et al., 1991; Nutter et al., 1994; Errol C. Friedberg, 2005]. 
Both of these unstable bulky adducts and oxidants produce AP sites and strand breakages 
[Errol C. Friedberg, 2005]. Estrogen is also implicated in the development of prostate 
cancer, where strand breaks and lipid peroxidation were the phenotypic readouts in a 
prostate rat model [Ho and Roy, 1994; Nelles et al., 2011].
Toxins
Natural toxins constitute a class of genotoxic and carcinogenic compounds, which are 
normally used by microorganisms or fungi in defense responses [Ames et al., 1990]. Human 
and animal exposures result from contaminated cereals, oilseeds, spices, tree nuts, milk and 
milk products [Lopez et al., 2002]. Aflatoxins are naturally occurring toxins from 
Aspergillus flavus and Aspergillus parasiticus, of which aflatoxin B1 is the most potent liver 
carcinogen [Bennett and Klich, 2003]. After passively diffusing into cells, aflatoxin B1 
(Figure 3F) is metabolized by the P-450 complex into the active form, aflatoxin B1-8,9-
epoxide. This reactive electrophile then adducts with N7 of guanine to form a positively 
charged product, 8,9-dihydro-8-(N7-guanyl)-9-hydroaflatoxin B1, which weakens the 
glycosidic bond resulting in depurination [Essigmann et al., 1977; Smela et al., 2001].
Environmental stresses
Environmental sources of stress such as extreme heat or cold, hypoxia, and oxidative stress 
have been shown to cause DNA damage in human cells [Gregory and Milner, 1994; Gafter-
Gvili et al., 2013; Luoto et al., 2013; Neutelings et al., 2013; Kantidze et al., 2016]. These 
stresses have also been shown to cause mutagenesis at trinucleotide repeats, which are 
implicated in the development of neurodegenerative disorders via the alt-NHEJ DNA repair 
pathway [Chatterjee et al., 2015; Chatterjee et al., 2016b]. Equally compelling is the 
observation that the pathway of environmental stress-induced mutagenesis is akin to the 
physiological genome instability program operational in many cancer cells [Chatterjee et al., 
2015; Chatterjee et al., 2016b]. It is of interest to know whether similar environmental 
stress-induced phenotypes can be recapitulated in mouse studies.
Other everyday use biological products have increasingly been associated with DNA 
damage. For example, butyl paraben (BP) and bisphenol A (BPA), found in cosmetics, 
pharmaceuticals, food-products and beverage processing, are linked to DNA damage in 
sperm cells [Oishi, 2002; Meeker et al., 2010a; Meeker et al., 2010b; Meeker et al., 2011]. 
Food preservatives [(sodium benzoate (SB), potassium benzoate (PB) and potassium sorbate 
(PS)] and food additives [(citric acid (CA), phosphoric acid (PA), brilliant blue (BB) and 
sunset yellow (SY)] are all known to cause DNA damage [Mamur et al., 2010; Zengin et al., 
2011; Yilmaz et al., 2014; Pandir, 2016]. Additionally, plant protection products (PPPs) 
regularly used by orchard workers have also been associated with DNA damage [Kasiotis et 
al., 2012]. Such instances stress the importance of global regulatory requirements on the use 
of chemicals that risk human health, as there may be yet unknown chemicals that have 
health risks.
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DNA damage response (DDR)
After the DNA is damaged, lesion-specific sensor proteins initiate a DNA damage response. 
The DDR is a collection of mechanisms that sense DNA damage, signal its presence and 
promote subsequent repair [Harper and Elledge, 2007]. Recruitment of DDR factors is a 
spatiotemporally regulated process, in which the DDR factors are assembled at the site of 
damage in a sequential and coordinated manner, as verified by time-lapse microscopy of 
discrete foci [Harper and Elledge, 2007; Ciccia and Elledge, 2010; Polo and Jackson, 2011]. 
In addition, chromatin remodeling is an important modulator of DDR response, whereby key 
post-translational modifications allow assembly of specific DDR and repair factors [Bekker-
Jensen et al., 2006; Harper and Elledge, 2007; Misteli and Soutoglou, 2009; Polo and 
Jackson, 2011; Altmeyer and Lukas, 2013a; Altmeyer and Lukas, 2013b; House et al., 
2014]. Mutations affecting DDR network components are the cause of several cancer 
predisposition syndromes, reflecting their overall importance in avoiding DNA damage-
induced human diseases [Ciccia and Elledge, 2010]. However, DNA repair pathways (Figure 
4) effectively remove most DNA lesions, which could otherwise result in the formation of 
mutations or block metabolic processes such as replication and transcription thereby causing 
senescence and cell death as we discuss below. Readers are directed to excellent reviews on 
the role of histone modifications during the DNA damage response [van Attikum and 
Gasser, 2005; Altaf et al., 2007; Zhu and Wani, 2010].
Repair of base DNA damage
Reversal of DNA damage
Small subsets of DNA lesions—UV photolesions and alkylated bases—are simply reversed 
in an error-free manner. Readers are directed to excellent literature sources on the 
photolyase-mediated photoreactivation of UV lesions found in lower organisms and 
marsupials [Kato et al., 1994; Errol C. Friedberg, 2005; Yi and He, 2013]. Here we will 
briefly discuss the reversal of alkylated DNA damage.
Two different classes of enzymes reverse alkylated bases in humans and mammals. First, the 
O6- alkylguanine-DNA alkyltransferase (AGT/MGMT) enzyme reverses O-alkylated DNA 
lesions, such as the O6-methyl, ethyl, 2-chloroethyl, benzyl and aliphatic groups, the 
pyridyloxobutyl adducts of guanine, and even repair the O6–G-alkyl-O6- G interstrand cross-
links [Tubbs et al., 2007; Fang et al., 2008; Pegg, 2011]. A single AGT molecule removes 
the alkylation adduct in a one step reaction by transferring the alkyl group from the oxygen 
of the DNA base to the cysteine residue in its catalytic pocket [Kaina et al., 2007]. AGT has 
a special and complex significance in the cancer field. On one hand, AGT’s potential to 
target a diverse set of substrates is exploited to synthesize pseudosubstrates that can be used 
in combination with therapeutic alkylating agents to circumvent resistance to cancer 
chemotherapy [Tubbs et al., 2007]. On the other hand, lack of AGT expression is associated 
with certain group of cancers [Lee et al., 2011; Mokarram et al., 2013]. In addition, 
alkyltransferase-like proteins (ATLs), a family of AGT homologs, inhibit the AGT enzyme 
by directing the repair of bulky alkyl damage to the NER pathway [Margison et al., 2007; 
Tubbs et al., 2009].
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The second class of direct reversal enzymes, the AlkB-related α-ketoglutarate-dependent 
dioxygenases (AlkB), reverse N-alkylated base adducts. There are 9 human homologs of E. 
coli AlkB, which are designated as ALKBH1-8 (Alkylation Repair Homologs) and FTO (Fat 
Mass and Obesity associated) in human cells [Kurowski et al., 2003; Gerken et al., 2007; 
Sanchez-Pulido and Andrade-Navarro, 2007; Yi and He, 2013]. For demethylation, the AlkB 
family proteins hydroxylate the alkyl group in a α-ketoglutarate and iron(II) dependent 
manner. The oxidized alkyl group is released as formaldehyde, leaving behind the original 
base [Drablos et al., 2004; Falnes et al., 2007].
Base excision repair (BER)
BER corrects those forms of oxidative, deamination, alkylation and abasic single base 
damage that are not perceived as significant distortions to the DNA helix. In the nucleus, this 
repair process is mainly active in the G1 phase of the cell cycle [Dianov and Hubscher, 
2013]. For BER transactions, chromatin remodeling at the DNA damage site is followed by 
lesion recognition by a DNA glycosylase [Odell et al., 2013]. At least 11 different DNA 
glycosylases can recognize and excise a damaged base from undistorted helices, as well as 
ones flipped out from the major groove [Huffman et al., 2005; Krokan and Bjoras, 2013]. In 
terms of function, DNA glycosylases are either monofunctional, with only a glycosylase 
activity, such as the uracil glycosylases, N-methylpurine DNA Glycosylase (MPG), and 
MutY Homolog (MUTYH), or are bifunctional with a glycosylase and an additional β-lyase 
activity. Examples of the latter include the Nth-like DNA glycosylase 1 (NTHL1), Nei-like 
DNA glycosylase 1 (NEIL1) and Nei-like DNA glycosylase 2 (NEIL2) [Jacobs and Schar, 
2012]. It should be noted that 8-oxoguanine DNA glycosylase (OGG1) and NEIL3 function 
as both mono- and bifunctional glycosylases [Svilar et al., 2011]. An abasic site created 
from the monofunctional glycosylases gets committed to the short-patch-repair pathway, 
while the bifunctional glycosylases initiate the long-patch repair pathway of BER [Dianov 
and Hubscher, 2013].
In short patch repair, the abasic site is the substrate for the AP endonuclease (APE1 in 
human cells), which cleaves the phosphodiester bond 5′ to the abasic site and generates a 
hydroxyl residue at the 3′-end while leaving a deoxyribose phosphate (dRP) at the 5′-end. 
This repair gap is tailored by the 5′-dRP lyase activity of POL β (gap tailoring), followed by 
filling the single nucleotide gap by POL β and ligation by either LIG1 (DNA ligase 1) or a 
complex of LIG3 (DNA ligase 3) and XRCC1 (X-ray repair cross-complementing protein 1) 
[Almeida and Sobol, 2007]. In long patch repair, the repair gap left behind from the 
bifunctional glycosylase is tailored by the 3′ phosphodiesterase activity of APE1. 
Thereafter, POL β (in non-proliferating cells) or POL δ/ε (in proliferating cells) synthesize 
in a strand-displacement manner, which is then followed by flap removal by the flap 
endonuclease and a LIG1-mediated ligation [Akbari et al., 2009; Svilar et al., 2011].
While BER of 8-oxo-G lesions at CAG repeats is implicated in triplet repeat instability, 
downregulation of OGG1 is associated with aging, neurodegenerative disorders and cancer 
[Kovtun et al., 2007; Tian et al., 2009; Curtin, 2012; Mollersen et al., 2012; Chatterjee N., 
2013; Krokan and Bjoras, 2013; Chatterjee et al., 2015]. Specifically, mutations in POL β 
are found in solid cancers and POL β variants can act as dominant negative and sequence 
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specific mutators [Wang et al., 1992; Starcevic et al., 2004; Lang et al., 2007; Murphy et al., 
2012]. In addition, PARP1 (Poly [ADP-ribose] polymerase 1) has also been shown to be 
required for the repair of single strand breaks and damaged purine bases by a sub-pathway 
of BER [Krokan and Bjoras, 2013; Reynolds et al., 2015]. Finally, mitochondria are also 
known to carry out both short and long patch BER, where the synthesis step is carried out by 
POL γ; all of which adds to the significance of this repair pathway in the maintenance of 
global genome stability [Akbari et al., 2008; Liu and Demple, 2010]. Readers are directed to 
these reviews for an overview of mitochondrial BER [Bauer et al., 2015; Prakash and 
Doublie, 2015].
Repair of multiple and bulky base damage
Nucleotide excision repair (NER)
Nucleotide excision repair is the pathway of choice to remove bulky lesions such as CPDs 
and (6 – 4)PP from UV radiation, benzo[a]pyrene adducts, or damage from 
chemotherapeutic agents. NER deficiency results in a number of different human 
syndromes: Xeroderma Pigmentosum (XP), which is associated with a predisposition to skin 
cancers; Cockayne Syndrome (CS); rare UV-Sensitive Syndrome (UVSS); and Cerebro-
Oculo-Facio-Skeletal syndrome (COFS) [Errol C. Friedberg, 2005; Vermeulen and Fousteri, 
2013]. However, like the BER pathway, NER contributes to the instability mechanisms in 
triplet repeat disorders [Lin et al., 2006; Hubert et al., 2011; Dion, 2014]. To begin NER, 
chromatin remodeling mediated both by chromatin and NER components makes way for the 
NER machinery on the specified DNA lesions [Scharer, 2013]. There are two major 
branches of NER: global genome NER (GG−NER) and transcription−coupled NER (TC
−NER).
In GG-NER, the main DNA damage sensor is the XPC (Xeroderma Pigmentosum, 
complementation group C) protein, complexed with RAD23B (UV excision repair protein 
Radiation sensitive 23B) protein and CETN2 (Centrin 2). This complex scans for the 
presence of transient single−stranded DNA (ssDNA) caused by disrupted base pairing due to 
the lesion [Masutani et al., 1994; Nishi et al., 2005]. For repair of UV-induced CPDs, the 
ultraviolet-damaged DNA damage−binding protein (UV–DDB) complex, consisting of 
DDB1 (XPE−binding factor) and the GG−NER−specific protein DDB2, directly binds to 
UV−radiation−induced lesions and then stimulates the binding of XPC [Chu and Chang, 
1988; Wakasugi et al., 2002; Scrima et al., 2008]. XPC bound to the lesion becomes the 
substrate for the transcription initiation factor II H (TFIIH) complex, a transcription 
initiation and repair factor composed of ten protein subunits that can switch functions in 
both transcription initiation and in NER [Yokoi et al., 2000; Volker et al., 2001; Compe and 
Egly, 2012]. The final step of dual excision and gap filling is coordinated to prevent the 
ssDNA gap formation that can potentially trigger DDR signaling [Marini et al., 2006; Marti 
et al., 2006; Mocquet et al., 2008].
The incision step of GG-NER commits the assemblage of all the proteins to NER. It involves 
the use of structure specific endonucleases XPF–ERCC1 and XPG (also known as ERCC5), 
which cuts the damaged strand short distances away from the 5′ and 3′ end of the lesion 
respectively [Fagbemi et al., 2011]. The replication proteins PCNA (proliferating cell 
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nuclear antigen), RFC (replication factor C), POL δ, POL ε or POL κ, and LIG1 or 
XRCC1–LIG3 carry out the final step of gap−filling synthesis and ligation. Proliferative 
status of the cell determines the choice of polymerase used. For example, POL ε−dependent 
repair predominates in non−replicating cells, while POL δ and POL κ are the main NER 
polymerases in replicating cells. LIG1-dependent ligation occurs in replicating cells. 
However, XRCC1–LIG3 complex seals the gap in non-proliferating cells because of low 
expression of dNTPs and LIG1 in these cells, [Moser et al., 2007; Ogi et al., 2010].
The second NER pathway, TC-NER, is initiated by a lesion-stalled RNA polymerase II, 
which begins with the recruitment of TC−NER−specific proteins CSA (Cockayne syndrome 
WD repeat protein A; also known as ERCC8) and CSB (Cockayne syndrome protein B; also 
known as ERCC6), which are essential for additional assembly of other TC−NER 
components [Fousteri et al., 2006]. These include the core NER factors (except for the GG
−NER− specific UV–DDB and XPC complexes) and TC−NER−specific proteins, such as 
UVSSA (UV−stimulated scaffold protein A), USP7 (ubiquitin−specific−processing protease 
7; also known as ubiquitin C−terminal hydrolase 7), XAB2 (XPA−binding protein 2; also 
known as pre−mRNA−splicing factor SYF1) and HMGN1 (high mobility group nucleosome
−binding domain−containing protein 1; also known as non−histone chromosomal protein 
HMG14) [Fousteri et al., 2006; Schwertman et al., 2012]. Once localized at the lesion site, 
the CSA-CSB complex backtracks (or reverse translocates) RNA polymerase II, exposing 
the lesion site. TFIIH is recruited to the lesion. The subsequent sequence of events is 
predicted to be the same as in GG-NER as the lesion is removed from the transcribed strand 
[Marteijn et al., 2014].
Mismatch repair (MMR)
MMR is an evolutionarily conserved, post replicative repair pathway that contributes to 
replication fidelity by at least 100-fold [Kunkel, 2009; Arana and Kunkel, 2010]. Typical 
substrates for the MMR pathway are base mismatches that have arisen during replication and 
the insertion-deletion loops (IDLs) within repetitive DNA sequences that have resulted from 
strand slippage events [Errol C. Friedberg, 2005; Jiricny, 2006]. MMR is also implicated in a 
variety of cellular processes including microsatellite stability, meiotic and mitotic 
recombination, DNA-damage signaling, apoptosis, class-switch recombination, somatic 
hypermutation and triplet-repeat expansion [Jiricny, 2006; Jiricny, 2013; Chatterjee et al., 
2016a]. Germline mutations in the MMR genes result in Lynch syndrome (also known as 
hereditary nonpolyposis colorectal cancer or HNPCC), which presents as a familial 
susceptibility to colon and ovarian cancers as well to a number of other cancers [Peltomaki, 
2001]. Chromatin modifications have recently been shown to pave the way for the MMR 
proteins to gain access to the DNA lesion and initiate repair [Li et al., 2013; Li, 2014].
Of the eight known MSH (MutS homolog) polypeptides in eukaryotes, humans employ the 
MutSα heterodimer (MSH2/MSH6) to recognize base mismatches and one-to-two 
nucleotide IDLs, and the MutSβ heterodimer (MSH2/MSH3) to recognize large IDLs 
[Kunkel and Erie, 2005; Sachadyn, 2010]. The previously accepted model was that after the 
lesion recognition step, the MutS complex translocates along the DNA in an ATP-dependent 
manner to make way for the downstream MMR components [Jiricny, 2013]. Recently, the 
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Modrich lab has shown that MutL can trap MutS at the mismatch before it forms a sliding 
clamp [Qiu et al., 2015]. Next, the MutL complexes are recruited on to DNA and among the 
4 known human MutL homologs; the MutLα heterodimer (MLH1/PMS2 heterodimer) plays 
a major role in MMR [Nicolaides et al., 1994; Papadopoulos et al., 1994; Li and Modrich, 
1995; Lipkin et al., 2000]. MutLα regulates termination of mismatch-provoked excision, and 
its endonuclease activity plays a role in the 3′ nick-directed digestion by EXO1 
(Exonuclease 1) in a PCNA/RFC dependent manner [Zhang et al., 2005; Kadyrov et al., 
2006]. EXO1 also carries out the 5′ directed mismatch excision creating a gap that is 
stabilized by RPA [Genschel and Modrich, 2003; Zhang et al., 2005]. POL δ, RFC, HMGB1 
(high mobility group box 1 protein) and LIG1 orchestrate the final steps of new DNA 
synthesis and ligation [Genschel and Modrich, 2003; Yuan et al., 2004; Guo et al., 2006]. 
PCNA plays an important role in both the initiation step of MMR and in the subsequent 
DNA synthesis by interacting and localizing MutSα/β and MutLα complexes at the lesion 
site [Umar et al., 1996; Lau and Kolodner, 2003; Jiricny, 2006].
In addition to mismatch repair and other cellular functions, the mismatch repair genes have 
recently been shown to be repressed in response to environmental stresses, such as hypoxia, 
benzo[a]pyrene, inflammation and even tumor microenvironment [Mihaylova et al., 2003; 
Bindra and Glazer, 2007; Nakamura et al., 2008; Edwards et al., 2009; Chen et al., 2013]. It 
remains to be seen whether other exogenous stresses can also suppress the expression of 
MMR genes.
Interstrand cross-link repair (ICL)
Interstrand crosslinks are lesions in which two bases from complementary strands are 
covalently linked due to damage to the DNA from crosslinking agents such as platinum 
compounds, nitrogen mustards, MMC, psoralens and alkylating agents [Clauson et al., 
2013]. Additional modifications from these crosslinking agents include bases monoadducts, 
intrastrand crosslinks, and DNA-protein crosslinks. These lesions are recognized and 
repaired by the Fanconi anemia (FA) proteins. Mutations in the FA genes are the cause of the 
autosomal recessive FA disorder. FA disorder is a heterogeneous and rare genetic disorder 
characterized with a high frequency of hematological abnormalities, congenital anomalies 
and a general predisposition to cancers [Kee and D’Andrea, 2012]. Classically, FA is 
diagnosed by assessing cellular hypersensitivity—chromosomal breaks and chromosomal 
radial formations—to DNA ICL agents such as diepoxybutane (DEB) and MMC [D’Andrea, 
2010]. In addition, DEB-induced chromosome breakage assay is widely used for the primary 
diagnosis of FA [Auerbach, 1993].
Interstrand crosslink repair is initiated by chromatin loading of the FA proteins in a cell 
cycle-dependent manner [Mi and Kupfer, 2005; Kim et al., 2008]. The FA family consists of 
21 different functional complementation groups (A, B, C, D1, D2, E, F, G, I, J, L, M, N, O, 
P, Q, R, S, T, U, V), which are known to suppress ICL sensitivity [Bluteau et al., 2016; 
Michl et al., 2016]. Upon ICL damage, FANCM is recruited to the damaged site along with 
FAAP24 (Fanconi Anemia associated protein of 24 kDa) and MFH (histone fold protein 
complex) [Ciccia et al., 2007; Niedernhofer, 2007; Yan et al., 2010]. Replication fork 
remodeling stimulated by MFH and FANCM promotes Holliday junction migration and the 
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creation of ssDNA gaps [Gari et al., 2008a; Gari et al., 2008b; Huang et al., 2010]. RPA 
bound ssDNA signals ATR activation [Zou and Elledge, 2003; Ben-Yehoyada et al., 2009]. 
ATR phosphorylates downstream target CHK1, which in turn phosphorylates FANCE, 
FANCD2, FANCI and MRN [Andreassen et al., 2004; Smogorzewska et al., 2007; Wang et 
al., 2007a; Cui et al., 2009; Duquette et al., 2012]. In a yet unknown way, other FA core 
complex components (FANCA/B/C/E/F/G/L/T) assemble at the damaged site and activate 
the phosphorylated FANCI–FANCD2 heterodimer through FANCL-mediated 
monoubiquitination [Smogorzewska et al., 2007]. This activation of FANCI-D2 marks as the 
major activation switch for the FA pathway [Wang, 2008; Tomida et al., 2013]. 
Subsequently, excision of the DNA strand (5′ and 3′) of the lesion is coordinated by 
structure specific endonucleases—XPF-ERCC1, MUS8-EME1, SLX4-SLX1, FAN1, 
SNM1A/SNM1B—in an as-yet unclear fashion [Clauson et al., 2013]. Next, depending 
upon the proliferation state of the cells, ICL repair bifurcates into either of the two pathways 
below.
In replicating cells, the presence of ICL stalls the ongoing replication on the leading strand, 
as well as on the 5′ end of the lagging strand at some distance from the lesion [Raschle et 
al., 2008; Knipscheer et al., 2009]. Next, XPF-ERCC1 and SNM1A induce incisions on 
either side of the lesion that unhook the ICL from the lagging strand, thereby producing a 
gap [Wang et al., 2011]. The leading strand with the ICL becomes the template for new 
DNA synthesis—by TLS polymerases POL ι, POL κ, POL ν and REV1—that proceeds up 
to the lesion, bypasses it, and extends beyond the lesion until it reaches the first downstream 
Okazaki fragment [Minko et al., 2008; Raschle et al., 2008; Yamanaka et al., 2010; Ho et al., 
2011; Klug et al., 2012]. After this step, the 3′ overhang of the leftover lagging strand 
invades the newly synthesized strand in a RAD51-dependent manner in a tightly coordinated 
manner [Long et al., 2011]. Interestingly, resolution of this HR intermediate depends on the 
FANCD2-FANCI complex. NER pathway eventually removes the ICL hook that was still 
hanging on to the leading strand.
In non-replicating cells, ICL repair of psoralen, MMC, cisplatin, and alkyl ICLs depend on 
NER and TLS polymerases such as REV1 and POL ζ [Clauson et al., 2013]. Helix-
distorting lesions are recognized by both the GG-NER and the TC-NER pathways to initiate 
repair, although some lesions such as cisplatin may escape recognition [Enoiu et al., 2012]. 
After lesion recognition, the components of the NER pathway are known to cut only the 5′ 
side of the lesion, with further incisions possibly aided by the MutSβ complex create a 
ssDNA-gap [Bessho et al., 1997; Mu et al., 2000; Smeaton et al., 2008; Zhao et al., 2009]. 
Next, the error-prone TLS polymerase synthesize across the gap and finally a second round 
of NER removes the ICL hook on the other strand [Clauson et al., 2013].
Recent studies provide a striking evidence of crosstalk between the FA and other repair 
pathways. For example, the FA pathway suppresses non-homologous end joining (NHEJ) by 
interacting with CtIP, and recruiting the NHEJ-inhibiting molecules—PARP1 and RAD18 to 
the DNA [Saberi et al., 2007; Ceccaldi et al., 2016a]. Similarly, inhibition of NHEJ 
components alleviates the sensitivity of FA deficient cells to crosslinking agents, while the 
same FA deficient cells show enrichment of 53BP1, RIF1 and RAP80 components at 
damaged chromatin [Adamo et al., 2010; Pace et al., 2010; Ceccaldi et al., 2016b; Renaud et 
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al., 2016]. A second intriguing example of the FA pathway’s crosstalk is its undefined role 
in promoting alternate end joining events, as seen in patients with FANCA mutations who 
lack immunoglobulin class switch recombination. In addition, loss of FANCD2 confers a 
synthetic lethal phenotype in POL θ null mice [Nguyen et al., 2014; Ceccaldi et al., 2015; 
Howard et al., 2015]. Finally, the FA pathway has now been implicated in trinucleotide 
repeat instability [Chatterjee N., 2016].
Translesion Synthesis (TLS)
Translesion synthesis is carried out by highly conserved TLS polymerases. TLS polymerases 
are specialized DNA polymerases that can replicate opposite and past aberrant DNA lesions 
in a relatively lower fidelity manner than replicative DNA polymerases [Sale, 2013]. If 
incorrect nucleotides were incorporated by TLS polymerases, they would become mutations 
in the next round of replication, which propel tumorigenesis and disease, but can also 
contribute to the overall fitness and evolution of organisms. A total of eleven TLS 
polymerases are known (REV1, POL η, POL ι, POL κ, POL ζ, POL μ, POL λ, POL β, 
POL ν, POL θ), which are distributed in four families (Y, B, X and A) and PrimPol (Table 
1). Although all TLS polymerases are less accurate than replicative polymerases, certain 
TLS polymerases are able to copy relatively accurately over certain cognate lesions. For 
example, cyclobutane thymine-thymine CPDs are cognate lesions for POL η (Table 1). The 
frequency of DNA synthesis errors during translesion synthesis depends on several factors, 
such as whether the lesion is a cognate for the particular TLS DNA polymerase, the 
biochemical characteristics of the particular TLS polymerase and the DNA sequence context 
[Pages and Fuchs, 2002; McCulloch et al., 2004; Waters and Walker, 2006]. XPV patients, 
who exhibit a photosensitive phenotype with a high incidence of skin cancer, highlight the 
physiological significance of certain TLS DNA polymerases bypassing particular lesions. 
These patients lack the POL η enzyme and are highly susceptible to UV radiation because 
alternate TLS polymerases (POL ι and POL κ) instead bypass the UV-induced cyclobutane 
dimers (CPD) in an error-prone fashion [Yamada et al., 2000; Sweasy et al., 2006; Wang et 
al., 2007b; Ziv et al., 2009].
The TLS polymerases’ fascinating ability to help cells tolerate DNA damage arises from 
their structural and biochemical features [Rothwell and Waksman, 2005; Pavlov et al., 2006; 
Waters and Walker, 2006]. Unique functional attributes of TLS polymerases that 
distinguishes them from the classical replicative polymerases, stems from their discrete 
physical features. Notable features include the very limited sequence homology to 
replicative DNA polymerases, the absence of a 3′-5′ exonuclease domain to proofread 
incoming nucleotides, and their smaller thumb and finger domains, which make fewer 
contacts with the DNA than those found in replicative DNA polymerases [Rothwell and 
Waksman, 2005; Waters and Walker, 2006; Sale, 2013]. These structural differences orient 
the thumb, fingers, palm, and little finger catalytic domains into a relatively larger open 
active site, while being aided by other physical features such as the polymerase-associated 
domain (PAD), wrist, and N-clasp region found in Y Family DNA polymerases that facilitate 
additional DNA binding. Together, these structural features provide the TLS polymerases 
with a unique architecture that enable them to bypass DNA damage or fill ssDNA gaps 
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[Trincao et al., 2001; Ling et al., 2003; Lone et al., 2007; Jansen et al., 2009a; Jansen et al., 
2009b].
Two models have been proposed to explain the DNA lesion bypass process via translesion 
synthesis. In the polymerase switch model, TLS polymerases come together sequentially in 
a two-step process to replicate pass the DNA lesion at a stalled replication fork. First, an 
‘inserter’ TLS enzyme, usually a POL η, POL ι, or POL κ, and less often REV1 or POL ζ, 
incorporates a nucleotide opposite the DNA lesion [Korzhnev and Hadden, 2016]. In the 
second step, an extender TLS enzyme, a role usually fulfilled by POL ζ exclusively but in 
some cases by POL κ, replaces the inserter polymerase and extends the primer-template 
termini [Washington et al., 2002; Yuji Masuda, 2016]. This two-step model is proposed to 
direct both the error-free and error-prone translesion DNA synthesis across the damage 
[Shachar et al., 2009]. The central molecule that orchestrates both the insertion and 
extension step is REV1, and by way of its unique scaffolding function facilitates an 
assemblage of the TLS polymerases by binding to an RIR-containing polymerase—POL η, 
POL ι, or POL κ—via one interface, and also to POL ζ4 (REV3-REV7-POLD2-POLD3), 
via a second interface, a central step in this model’s execution [Wojtaszek et al., 2012a; 
Wojtaszek et al., 2012b]. Moreover, POLD3, which is part of the POL ζ4 complex, interacts 
with REV1 via its RIR, thereby assisting the switch from RIR directed insertion to POL ζ4-
mediated extension during damage bypass [Pustovalova et al., 2016].
In the gap-filling model, single strand gaps left behind by replicative polymerases during 
replication or via an incomplete DNA repair process, such as during immunoglobulin gene 
hypermutation, are the targets of TLS synthesis [Sale et al., 2009]. Usually, these type of 
TLS events are expected to fall outside of the S phase, but based on the type of DNA lesion, 
a cell-cycle independence is sometimes conferred [Quinet et al., 2016]. Using a gapped 
plasmid assay, it has been shown that TLS is as high or higher in G2 compared to S phase in 
human cells, with slightly higher amounts of POL η in G2 compared to S phase of the cell 
cycle [Diamant et al., 2012]. An exact order of events for a gap-TLS is still unknown, with 
only a few isolated studies implying the role of TLS polymerases in gap filling. For 
example, REV1 is very important in mouse cells for synthesis across post-replicative gaps 
where REV1 gets recruited to the gaps by the 5′-end, unlike the gap-filling step of NER, 
where POL κ is the polymerase of choice [Ogi and Lehmann, 2006; de Groote et al., 2011; 
Sale, 2013]. Likewise, REV3 engages in TLS across gaps opposite 6-4 photoproducts 
[Quinet et al., 2016], all suggestive of a role of TLS at replicating across ssDNA gaps.
In addition to their traditional DNA damage bypass functions, TLS polymerases are now 
known to play a role in other cellular pathways. For instance, as previously discussed, TLS 
polymerases are required for ICL repair and can also play role in the BER and NER 
pathways to synthesize new DNA after the excision step. Exogenous stressors—for example 
UV-C, MNNG, and BPDE—regulate the transcriptional expression of POL η, POL ι, POL 
κ and POL ζ [Zhu et al., 2003; Yu et al., 2004; Liu and Chen, 2006; Zhu et al., 2010; Zhu et 
al., 2012]. Likewise, an HSP90 inhibitor reduces expression of REV1 and POL η in human 
cells, indicating an evolutionary regulation of these polymerases [Sekimoto et al., 2010; 
Pozo et al., 2011]. Interestingly, the TLS polymerases, REV1 and REV3, were also 
implicated in the development of chemoresistance in human cells and mice models, opening 
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the possibility for a whole new class of promising chemotherapeutic drugs [Doles et al., 
2010; Xie et al., 2010; Xu et al., 2013].
Repair of DNA breaks
Single stranded break repair (SSBR)
Single strand breaks (SSBs) are often generated from oxidative damage to the DNA, from 
abasic sites, or from erroneous activity of the DNA topoisomerase 1 (TOP1) enzyme [Wang, 
2002; Hegde et al., 2008]. Unresolved SSBs often collapse DNA replication, stall ongoing 
transcription, and effect PARP1 activation, which releases cellular NAD+, ATP and 
apoptosis inducing factor (AIF) in cells [Zhou and Doetsch, 1993; Heeres and Hergenrother, 
2007] At least two human genetic disorders, spinocerebellar ataxia with axonal neuropathy 1 
(SCAN1) and ataxia-oculomotor apraxia 1 (AOA1), are associated with an abortive SSBR. 
These patients often manifest genetic instability and high incidence of cancers [El-Khamisy 
et al., 2005; Reynolds et al., 2009]. SSBR is predicted to occur through three different 
pathways depending on the source of SSB.
In the long patch SSBR pathway, SSBs are transiently detected by PARP1, which undergoes 
a rapid cycle of poly(ADP) ribosylation and dissociates to detect the next SSB [D’Amours et 
al., 1999; Davidovic et al., 2001]. After this, the ends undergo end processing by the 
apurinic-apyrimidic endonuclease 1 APE1, PNKP (polynuceotide kinase 3′-phosphate) and 
aprataxin (APTX) [McKinnon and Caldecott, 2007]. Next, FEN1 removes the damaged 5′ 
termini aided by PARP1 and PCNA, leaving behind a ssDNA gap, which is filled by POL β, 
in combination with POL δ/ε. The final step of ligation is carried out by the LIG1, which is 
dependent on the presence of PCNA and XRCC1 [Lan et al., 2004; Mortusewicz et al., 
2006; McKinnon and Caldecott, 2007]. In the short patch SSBR pathway, SSBs generated 
during the BER are recognized by APE1 followed by a similar end-processing pathway as 
the long patch repair. The gap-filling step, however, is only carried out by POL β enzyme, 
followed by LIG3-catalyzed ligation [McKinnon and Caldecott, 2007]. Finally, the TOP1-
SSB pathway is a variant of the PARP1-dependent long patch repair in which the end-
processing is carried out by the TDP1 (tyrosyl-DNA phosphodiesterase 1) enzyme that 
removes the TOP1 from the 3′-end [Caldecott, 2008].
Double strand break repair (DSBR)
Highly toxic DSBs are induced by various chemical and physical DNA damaging agents 
[Pfeiffer et al., 2000]. Unresolved DSBs are implicated in various human disorders and 
cancers [Jackson and Bartek, 2009]. We will briefly discuss the two major pathways—
homologous recombination (HR) and non-homologous end joining (NHEJ)—that organisms 
have evolved to resolve the DSBs. Chromatin modification is the first event that registers the 
presence of a DSB and triggers a cascade of events including ATM activation, targeted 
phosphorylation of H2AX, chromatin PARylation, MDC1 recruitment and finally 
recruitment of 53BP1 and BRCA1 [Rogakou et al., 1998; Rothkamm et al., 2003; 
Gottschalk et al., 2009; Chou et al., 2010; Lukas et al., 2011; Price and D’Andrea, 2013; Liu 
et al., 2014]. Interestingly, both 53BP1 and BRCA1 exhibit an antagonistic influence on 
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each other and 53BP1 depletion rescues embryonic lethality of BRCA1 null mice [Xie et al., 
2007; Cao et al., 2009; Bunting et al., 2010].
In the NHEJ pathway of DSBR, 53BP1 plays an important regulatory role by recruiting the 
NHEJ components to the break site, activating checkpoint signaling and facilitating synapsis 
of the two ends [Panier and Boulton, 2014]. The Ku (Ku70 and Ku80) heterodimer is the 
first to recognize and bind the DSBs within seconds to prevent end resection and serves as a 
scaffold to recruit other NHEJ components [Pang et al., 1997; Mari et al., 2006; Soutoglou 
et al., 2007; Mimitou and Symington, 2010]. Other recruited components include DNA-
PKcs, XRCC4, LIG4 and XLF (XRCC4-like factor), APLF (Aprataxin-and-PNK-like 
factor) [and also TdT (terminal deoxynucleotidyl transferase) in lymphocytes] [Gottlieb and 
Jackson, 1993; Nick McElhinny et al., 2000; Costantini et al., 2007; Yano et al., 2008; 
Grundy et al., 2013]. Recent studies indicate that the order of recruitment of these 
components may depend on the complexity of DNA damage; for instance, DNA-PKcs 
recruitment depends on the nature of the break [Mari et al., 2006; Yano and Chen, 2008]. 
However, once DNA-PKcs gets recruited, it is activated in a DNA dependent manner; it 
pushes Ku inwardly on the DNA and then phosphorylates other nearby components, 
including autoautophosphorylating itself [Gottlieb and Jackson, 1993; Yoo and Dynan, 
1999; Weterings and Chen, 2008]. At the same time, XRCC4 is believed to help stabilize the 
NHEJ complex by tethering the ends and acting as an additional scaffold with Ku to recruit 
other components [Malivert et al., 2010; Hammel et al., 2011; Andres et al., 2012]. Once the 
ends are bridged and stabilized, Artemis, PNKP, APLF, WRN, Aprataxin and Ku initiate 
DNA end processing, which involves removing groups that are blocking the ends and 
resecting the resultant naked strands [Ma et al., 2002; Bernstein et al., 2005; Ahel et al., 
2006; Perry et al., 2006; Roberts et al., 2010; Li et al., 2011]. The gaps left behind after 
resection are filled by family X polymerases in a template-dependent (POL μ) or template-
independent (POL λ) manner [Ramadan et al., 2004; Roberts et al., 2010]. LIG4 joins the 
ends and completes the NHEJ process [Grawunder et al., 1997].
The HR pathway consist of a set of related sub-pathways that utilize DNA strand invasion 
and template-directed DNA repair synthesis to effect a high-fidelity repair [Li and Heyer, 
2008]. In addition to the traditional DSBR-induced HR pathway, synthesis-dependent strand 
annealing (SDSA) and break-induced repair (BIR) are two other variations following the HR 
premise [Li and Heyer, 2008]. Here, we will very briefly summarize the HR pathway of 
DSBR.
The MRN (MRE11-RAD50-NBS1) complex initiates HR at a DSB, where it recognizes and 
binds the DSB and then recruits ATM and TIP60 to the DNA [Sun et al., 2005; Stracker and 
Petrini, 2011]. Activated ATM (from TIP60) phosphorylates H2AX, which then serves as an 
anchor for MDC1 [Bhatti et al., 2011]. Next, MDC1 is phosphorylated by ATM, and the 
phosphorylated MDC1 functions as a scaffold to bring in the ubiquitin E3 ligases RNF8 and 
RNF168 [Altmeyer and Lukas, 2013b]. Both of these E3 ligases ubiquitinate H2AX, which 
then serves as a docking site for 53BP1 and BRCA1. In the S/G2 phase where HR is 
predominant, BRCA1 (recruited by ubiquitinated chromatin) successfully counteracts 
53BP1 and initiates ubiquitination of the downstream component, CtIP [Yu et al., 2006; 
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Chapman et al., 2012]. At this time, the other HR components, RPA, and RAD51 proteins 
make their way on to the DNA.
The next step of end resection involves a 5′-to-3′ nucleolytic degradation to generate 3′ 
overhangs, committing cells to the HR pathway. Initial resection occurs by the endonuclease 
activity of MRN, with the help of CtIP, followed by long-range resection by EXO1 or BLM 
together with DNA2 [Chen et al., 2008; Nimonkar et al., 2011]. Next, RPA coats the 3′ 
overhang, which is then displaced by RAD51, generating a nucleoprotein filament. BRCA2 
and PALB2 aid in the formation of the nucleoprotein filament formation that invades a 
nearby duplex DNA forming a D-loop [Zhang et al., 2009; Holloman, 2011]. Several other 
proteins function together at this step. For the strand to invade the template DNA, RAD54 
and RAD54B remove RAD51 and allow the 3′-OH group to prime synthesis by 
Polymerases δ, κ and ν [Mazin et al., 2010; Sebesta et al., 2013]. If the new DNA synthesis 
stops after a limited distance, as is the case in SDSA, the RTEL1 enzyme dissolves the D-
loop [Barber et al., 2008]. Otherwise, the Holliday junction is collectively processed by the 
BLM-TOPOIII-RMI1-RMI2 complex, GEN1 endonuclease, the MUS81-EME1 complex 
and the SLX1-SLX4 complex [Chang et al., 2008; Ciccia et al., 2008; Xu et al., 2008; 
Fekairi et al., 2009; Rass et al., 2010].
DNA damage and telomeres
Telomeres are well-conserved nucleoprotein structures found at the end of linear 
chromosomes that help differentiate normal chromosomal ends from DSBs [Longhese, 
2008; Shammas, 2011]. Telomeric DNA consists of tandem repetitive DNA (TTAGGG in 
humans), where the G-rich strand (also called the G-tail), bound by sheltrin protein POT1 
(protection of telomeres 1), extends beyond the complementary C-rich strand and invades 
into the double-stranded telomeric DNA. The t-loop thus generated complexes with other 
sheltrin proteins such as TRF1 (telomeric-repeat binding factor 1), TRF2, TIN2 (TRF-
interacting protein 2), the transcriptional repressor/activator protein RAP1, and the TPP1 
(POT1- and TIN2- organizing protein), which together prevent the chromosomal ends from 
being recognized as DNA damage [Takai et al., 2003; d’Adda di Fagagna et al., 2004; Liu et 
al., 2004; de Lange, 2005]. In addition, telomeric DNA is replicated and maintained by a 
specialized ribonucleoprotein complex called telomerase [composed of a telomere RNA 
component (TERC) and a telomere reverse transcriptase (TERT)], which is the only positive 
regulator of telomere length [Bachand et al., 2001; Blasco, 2003]. A decline in telomerase 
activity contributes to telomere attrition, which is associated with aging, cancer and several 
inherited bone marrow failure (IBMF) disorders [Chang and Harley, 1995; Shay et al., 2001; 
Alter et al., 2015].
Deprotected telomeres elicit a DNA damage response, recruiting DSBR components that 
attempt to repair the exposed ends, causing deleterious nucleolytic degradation, 
recombination, and chromosomal fusions [Longhese, 2008]. For example, short telomeres 
often assemble DDR factors such as 53BP1, ATM, γH2AX, and MRE11 as foci, called 
Telomere Dysfunction-Induced Foci (TIF), which are highly prone to NHEJ-mediated end-
to-end fusion [Takai et al., 2003; Hewitt et al., 2012; Marcand, 2014]. Surprisingly, telomere 
maintenance requires the presence of some of the same components of DSBR/NHEJ 
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components—for example, Ku and the MRN complex—complicating our understanding of 
the exact mechanism of telomere stability [Maser and DePinho, 2004; Marcand, 2014]. 
Establishing the dynamics of this telomere biology is an active area of research.
Recently, several environmental toxins have been implicated in telomere shortening. For 
example, tobacco smoke causes telomere shortening via oxidative stress [Valdes et al., 2005; 
McGrath et al., 2007; Song et al., 2010; Babizhayev and Yegorov, 2011]. Obesity has also 
been associated with accelerated shortening of telomeres in adipose tissue of mice, where 
levels of ROS were high [Song et al., 2010]. Likewise, white blood cells of obese women 
harbor shorter telomeres than lean women [Valdes et al., 2005]. Genotoxic stressors such as 
certain pollutants (e.g. toluene and benzene, and PAHs) are also associated with telomere 
shortening [Hoxha et al., 2009; Pavanello et al., 2010; Trusina, 2014]. Finally, everyday 
stresses, including psychological stress, is known to shorten telomeres, whereas meditation 
and mindfulness may bring about an opposite effect [Epel et al., 2004; Cherkas et al., 2006; 
Simon et al., 2006; Epel et al., 2009; Mathur et al., 2016]. Critically shortened telomeres are 
associated with aging and cancer [Shammas, 2011].
Conclusion
In conclusion, DNA is continually being exposed to both endogenous and exogenous DNA 
damaging agents that chemically modify the DNA constituents. Unresolved DNA damages 
are implicated in human diseases and cancers. However, robust DNA repair and damage 
tolerance pathways help remove or tolerate the lesions to allow survival (Figure 4). An 
understanding of these pathways helps evaluate possible toxic exposures and design 
strategies to control deleterious consequences on human health.
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Figure 1. 
Common DNA base lesions. A) Normal structures of DNA bases: adenine (A), guanine (G), 
cytosine (C) and thymine (T). B) Deaminated bases: hypoxanthine, xanthine, uracil and 
thymine arising from deamination of exocyclic bases of adenine, guanine, cytosine and 5-
methylcytosine (5-mC) respectively. C) Oxidized DNA bases: formamidopyrimidine 
derivative of adenine (Fapy-A), 7,8 dihydro-8-oxoguanine (8-oxo-G) and thymine glycol. D) 
Methylated DNA bases: N3-methyladenine, N7-methylguanine, O6-methylguanine, N3-
methylcytosine, O4-methylthymine, O4-ethylthymine and N3-methylthymine.
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Figure 2. 
Main UV radiation-induced DNA base lesions. A) Representative cyclobutane pyrimidine 
dimers (CPD). Shown here are cyclobutane thymine dimers. B) Representative pyrimidine (6 
– 4) pyrimidone photoproduct [(6 – 4)PP]. Shown here are derivatives of two thymine bases 
linked via C6 of one thymine base and C4 of the other thymine base.
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Figure 3. 
Structures of representative DNA damaging agents. A) Alkylating agents: methyl 
methanesulfonate (MMS), ethyl methanesulfonate (EMS), N-methyl -N′ –nitro-N-
nitrosoguanidine (MNNG) and methylnitrosourea (MNU). B) Crosslinking agents: 
Cyclophosphamide, cisplatin and psoralen. C) Aromatic amines: 2-aminofluorene (AF) and 
N-acetyl-2-aminofluorene (AAF). D) Polycyclic aromatic hydrocarbons: benzo(a)pyrene 
and dibenzo[a,l]pyrene. E) Reactive electrophiles: 4-nitroquinoline 1-oxide (4-NQO). F) 
Toxins: Afaltoxin B1.
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Figure 4. 
Schematic of various DNA damage-induced DNA repair pathways. A variety of DNA 
damaging agents can induce DNA damage, which becomes substrate for specific DNA 
repair pathways. Upper panel shows representative DNA damaging agents: errors from 
replication, spontaneous base deamination, alkylating agents, toxins, oxidative agents, 
ionizing radiation, UV radiation, crosslinking agents, aromatic compounds and 
environmental agents such as heat, cold and hypoxia. Middle panel represents different 
kinds of damaged DNA: base mismatches (C:T), uracil from deamination of cytosine, an 
abasic site from the loss of a base from one DNA strand, methylated guanine, methylated 
adenine, 8-oxo-G lesion, thymine glycols, single strand breaks, double strand breaks, 
intrastrand cyclobutane thymine dimers and interstrand guanine crosslinks. The lower panel 
lists the specific DNA repair pathways that are instigated to repair DNA damages: mismatch 
repair corrects replication errors and other base mismatches; base excision repair removes 
base adducts, uracil, abasic sites and oxidative lesions; single strand break repair pathways 
repairs single stranded breaks in the DNA backbone; double strand break repair pathway 
repair double strand breaks; nucleotide excision repair removes bulky lesions and intrastrand 
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crosslinks; interstrand crosslink repair removes interstrand linkages and translesion synthesis 
bypasses intrastrand crosslinks and bulky lesions.
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Table 1
Shows representative human DNA polymerases. BER (base excision repair), MMR (mismatch repair), NER 
(nucleotide excision repair), DSBR (double strand break repair), dCTP (deoxycytidine phosphate), FA 
(fanconi anemia), TLS (translesion synthesis), SHM (somatin hypermutation), ICL (interstrand cross link), 
dRP (deoxyribosephosphate), TdT (Terminal deoxynucleotidyl transferase), RT (reverse transcriptase), AEP 
(archaeo-eukaryotic primases).
Polymerase Family Error Rate Function
α (POLA) B 10−4 – 10−5 An RNA primase during replication; role in S-phase checkpoint
β (POLB) X 5 X 10−4 A dRP and AP lyase; role in BER
δ (POLD) B 10−5 – 10−6 Has a 3′-5′ exonuclease activity; role in replication; additional roles in BER, MMR, 
DSBR, NER
ε (POLE) B 10−6 – 10−7 Has a 3′-5′ exonuclease activity; role in replication; additional roles BER, MMR, 
DSBR, NER and S-phase checkpoint
REV1 (REV1) Y Incorporates only dCTPs Incorporates only dCTPs and mediate protein-protein interactions during TLS; role in 
FA, HR
ζ (REV3) B 10−3 Roles in TLS, DSBR, FA and SHM
η (POLH) Y 3.5 X 10−2 Roles in TLS, SHM, BER
ι (POLI) Y 10−1 – 10−4 Roles in TLS, SHM, BER
κ (POLK) Y 10−2 – 10−3 Roles in TLS and NER
θ (POLQ) A 2.4 X 10−3 Has a helicase motif; ICL repair
γ (POLG) A 10−5 Has a 3′-5′ exonuclease activity; role in mitochondrial replication; BER
λ (POLL) X 1.5 X 10−4 A dRP lyase; roles in V(D)J recombination, NHEJ and BER
μ (POLM) X 10−3 – 10−5 A terminal transferase; roles in V(D)J recombination and NHEJ
ν (POLN) A 3.5 X 10−3 Possibly TLS
σ (POLS) X unknown Has a 3′-5′ exonuclease activity; role in sister chromatid exchange
Tdt X unknown V(D)J recombination, template independent synthesis
Telomerase RT 2 X 10−3 Replicates the ends of chromosomes
PrimPol AEP unknown Translesion polymerase with high efficiency
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